Frisch Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$728K Buy
1,871
+8
+0.4% +$3.11K 0.18% 67
2025
Q1
$810K Buy
1,863
+7
+0.4% +$3.04K 0.23% 56
2024
Q4
$685K Buy
1,856
+8
+0.4% +$2.95K 0.21% 56
2024
Q3
$961K Buy
1,848
+5
+0.3% +$2.6K 0.29% 48
2024
Q2
$999K Sell
1,843
-138
-7% -$74.8K 0.3% 45
2024
Q1
$1.03M Buy
1,981
+6
+0.3% +$3.11K 0.34% 40
2023
Q4
$931K Sell
1,975
-17
-0.9% -$8.01K 0.35% 43
2023
Q3
$867K Buy
+1,992
New +$867K 0.35% 44
2023
Q1
Sell
-2,116
Closed -$1.09M 123
2022
Q4
$1.09M Buy
2,116
+5
+0.2% +$2.56K 0.41% 48
2022
Q3
$959K Buy
2,111
+6
+0.3% +$2.73K 0.41% 43
2022
Q2
$1.02M Sell
2,105
-1
-0% -$483 0.39% 42
2022
Q1
$1.03M Sell
2,106
-179
-8% -$87.9K 0.33% 48
2021
Q4
$1.06M Sell
2,285
-109
-5% -$50.5K 0.33% 51
2021
Q3
$892K Buy
2,394
+7
+0.3% +$2.61K 0.3% 50
2021
Q2
$912K Sell
2,387
-151
-6% -$57.7K 0.29% 54
2021
Q1
$911K Sell
2,538
-36
-1% -$12.9K 0.31% 50
2020
Q4
$826K Buy
2,574
+108
+4% +$34.7K 0.3% 42
2020
Q3
$662K Buy
2,466
+9
+0.4% +$2.42K 0.29% 47
2020
Q2
$646K Buy
2,457
+9
+0.4% +$2.37K 0.31% 41
2020
Q1
$556K Sell
2,448
-113
-4% -$25.7K 0.32% 46
2019
Q4
$773K Buy
2,561
+7
+0.3% +$2.11K 0.37% 44
2019
Q3
$613K Buy
2,554
+204
+9% +$49K 0.37% 43
2019
Q2
$663K Buy
2,350
+13
+0.6% +$3.67K 0.44% 40
2019
Q1
$671K Sell
2,337
-173
-7% -$49.7K 0.41% 47
2018
Q4
$659K Buy
+2,510
New +$659K 0.46% 49